News from oramed pharmaceuticals inc. A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Dec 01, 2010, 09:20 ET

Oramed Pharmaceuticals Announces Publication in the Journal of Diabetes Science and Technology

Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) ( http://www.oramed.com), a developer of oral drug delivery solutions, announces a publication in the...

Nov 15, 2010, 09:20 ET

Oramed Pharmaceuticals Presents Results of its Phase IIb Clinical Trial at the Diabetes Technology Meeting 2010 in Bethesda, MD

Oramed Pharmaceuticals Inc. (OTCBB: ORMP) (http://www.oramed.com), a developer of oral drug delivery systems, presented the results of its recently...

Oct 26, 2010, 09:20 ET

Oramed Pharmaceuticals to Present Results of an Oral Insulin Administration Study at the Tenth Annual Meeting of the Diabetes Technology Society (November 11-13, 2010; Bethesda, MD)

Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) (http://www.oramed.com), a developer of oral drug delivery systems, announced today that its work...

Jul 07, 2010, 09:14 ET

Oramed Pharmaceuticals and sanofi-aventis Enter Into an Agreement for the Insulin Supply of Oramed's Oral Insulin Capsules

Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) (http://www.oramed.com), a developer of oral delivery systems, today announced that Oramed entered...

Jun 28, 2010, 09:17 ET

Oramed Pharmaceuticals to Present at the 70th Scientific Sessions of the American Diabetes Association

- Results of First Exposure of Type I Diabetes Patients to Oramed's Oral Insulin and of a First-in-Humans Study With its Oral GLP-1 Analog Oramed...

Jun 15, 2010, 08:58 ET

Oramed Pharmaceuticals was Chosen to Present Two Abstracts at the 70th Scientific Sessions of the American Diabetes Association in Orlando, FL, June 25-29, 2010

Oramed Pharmaceuticals, Inc. (OTCBB: ORMP) (http://www.oramed.com), a developer of alternative drug delivery systems, announced today that results...

Jun 08, 2010, 09:18 ET

Oramed Pharmaceuticals to Present at the 9th National Life Science & Technology Week ILSI -BIOMED Conference, Israel 2010

Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB), (http://www.oramed.com), a developer of oral delivery systems, today announced today that it was...

Jun 02, 2010, 09:14 ET

Oramed Pharmaceuticals Forms Joint Venture - Launches Entera Bio Ltd.

Oramed Pharmaceuticals Inc. (OTCBB: ORMP), a developer of oral drug delivery systems, announced today that its subsidiary Oramed Ltd. entered into...

May 26, 2010, 09:19 ET

Oramed Pharmaceuticals Announces Publication of Research Article on its Oral Insulin Capsule ORMD-0801 in Diabetes, Obesity and Metabolism

- Study Data Shows ORMD-0801 Resulted in Glucose and C-Peptide Reduction Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) (http://www.oramed.com),...

May 18, 2010, 09:19 ET

Oramed Pharmaceuticals Announces That Dr. Michael Berelowitz, Senior Vice President at Pfizer, Joins its Board of Directors

Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) announced that Dr. Michael Berelowitz, MD, joins Oramed Pharmaceuticals' Board of Directors. Dr....

May 06, 2010, 09:10 ET

Oramed Pharmaceuticals Reports Results in Phase 2b Trial of Oral Insulin Administration to Type 2 Diabetes Patients

Oramed Pharmaceuticals Inc. (OTCBB: ORMP), a developer of alternative drug delivery systems, reported today results for the recently completed...

Mar 25, 2010, 13:10 ET

Oramed Announces Completion of Pivotal Phase 2b Clinical Trials of it's Oral Insulin Capsule, ORMD-0801 for Type 2 Diabetes

Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) announced today the completion of its' pivotal Phase 2b clinical study of its oral insulin capsule,...

Feb 16, 2010, 09:20 ET

Oramed Pharmaceuticals Expands Scientific Advisory Board With the Appointment of John Amatruda, M.D.

- Dr. Amatruda is the Former Senior Vice President and Franchise Head of the Diabetes and Obesity Unit at Merck & Co. Oramed Pharmaceuticals,...

Feb 10, 2010, 09:20 ET

Oramed's Chief Scientific Officer, Miriam Kidron, Ph.D., Chosen to Lecture at the Third International Conference on Advanced Technologies and Treatments for Diabetes in Basel, Switzerland

Oramed Pharmaceuticals, Inc. (OTCBB: ORMP.OB) (http://www.oramed.com), a developer of alternative drug delivery systems, announced today that its...

Jan 19, 2010, 09:15 ET

Oramed Pharmaceuticals Announces Completion of Patient Enrollment for Pivotal Phase 2B Clinical Trials of ORMD-0801

- Key Trial for Oral Insulin With Expected Results at the End of Q1 of 2010 Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB) announced today...

Jan 11, 2010, 13:18 ET

Oramed Pharmaceuticals Announces Filing of Two Registration Statements

Oramed Pharmaceuticals Inc. (OTCBB: ORMP.OB), a developer of alternative drug delivery systems, today announced that it has filed two...

Jan 05, 2010, 09:15 ET

Oramed Pharmaceuticals to Present at OneMedPlace Finance Forum in San Francisco, California

Oramed Pharmaceuticals, Inc. (OTC BB: ORMP.OB) (http://www.oramed.com), a developer of alternative drug delivery systems, today announced that the...

Dec 21, 2009, 08:20 ET

Oramed's Dr Roy Eldor was Chosen to Lecture at the First International Conference Held by the Bildirici Center for Diabetes Care Research in Israel.

Oramed Pharmaceuticals, Inc. (OTCBB: ORMP.OB) (http://www.oramed.com), a developer of alternative drug delivery systems, announced today that...

Oct 20, 2009, 09:15 ET

Oramed Pharmaceuticals was Chosen to Present Results of a GLP-1 Analog Oral Administration Study at the Diabetes Technology Society's Ninth Annual Meeting (November 5-7, 2009; San Francisco, CA)

Oramed Pharmaceuticals, Inc. (OTCBB: ORMP.OB; http://www.oramed.com), a developer of oral drug delivery systems, announced today that its poster...

Sep 09, 2009, 09:15 ET

Oramed Pharmaceuticals Commences Human Clinical Trials of an Oral GLP-1 Analog

Oramed Pharmaceticals, Inc. (OTCBB: ORMP.OB), a developer of oral drug delivery systems, announced today that it has received approval from the...